Vimarsana
Biggest News Aggregation in the World

Page 13 - Ted White News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ted White. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ted White Today - Breaking & Trending Today

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma - Vimarsana News

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

There are approximately 3-4 million diagnoses of basal cell carcinomas in the U.S. each year, with a high unmet need for new treatment options Company reiterates lesion clearance data from Part 2...

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a ... - Vimarsana News

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a ...

There are approximately 3-4 million diagnoses of basal cell carcinomas in the U.S. each year, with a high unmet need for new treatment options

Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts - Vimarsana News

Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts

WEST CHESTER, Pa., Jan. 04, 2024 -- Verrica Pharmaceuticals Inc. , a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that...

Verrica Issues Statement On Type C Meeting With FDA Regarding Development Plan For YCANTH - Vimarsana News

Verrica Issues Statement On Type C Meeting With FDA Regarding Development Plan For YCANTH

Verrica Pharmaceuticals Inc. (VRCA) said it received the minutes from the company's recent Type C meeting with the FDA, which was held on November 6, 2023, to discuss the Phase 3 clinical development plan for YCANTH for the treatment of common warts.

7 people taken to hospital after crash between car and cyclists in Delray Beach - Vimarsana News

7 people taken to hospital after crash between car and cyclists in Delray Beach

Delray Beach fire officials said seven people were taken to the hospital Thursday morning following a crash involving a car and a group of bicyclists in Gulf Stream.

Source: wptv.com